Industry / Cuba
Biotech Industry Looks To Sea
March 2008 | Industry NewsDemonstrating the innovative strength of Cuba's biotech industry, researchers at the Marine Bioproducts Center (Cebimar) are advancing the development of two drugs derived from the ocean. The news follows an evaluation of around 100 compounds extracted from sea plants and animals in the early 2000s in a project that involved Cebimar and the Ministry of Science, Technology and the
Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Americas Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Americas Pharma & Healthcare Insight please click on the trial link below.
